You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progression free survival

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Chemotherapeutic Toxicity, Survivorship Trial in Nijmegen, Utrecht (Continuous aerobic and resistance

Recruiting
  • Colorectal Cancer
  • +3 more
  • Continuous aerobic and resistance exercise intervention
  • Continuous aerobic and aerobic interval exercise intervention
  • Almere, Netherlands
  • +11 more
Oct 25, 2022

Recurrent Cervical Carcinoma, Radiotherapy, Epidermal Growth Factor Receptor Trial in Beijing (Combination of nimotuzumab and

Recruiting
  • Recurrent Cervical Carcinoma
  • +6 more
  • Combination of nimotuzumab and radiotherapy
  • Beijing, Beijing, China
    Lei Li
Dec 18, 2020

Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma Trial in United States (dietary supplement, biological,

Active, not recruiting
  • Follicular Lymphoma
  • +3 more
  • Vitamin D
  • +2 more
  • Miami, Florida
  • +6 more
Mar 6, 2022

Prognostic Factors Affecting Recurrence and Disease-Free

Recruiting
  • Rectal Cancer
  • curative surgery for cancer rectum
  • Qinā, Egypt
    Qena Faculty of Medicine, South Valley University Hospitals
Oct 21, 2023

Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

Not yet recruiting
  • Renal Cell Carcinoma
  • Neoadjuvant
  • Axitinib plus Toripalimab
  • radical nephrectomy
  • (no location specified)
Feb 12, 2023

Survival Analysis in Children and Adults Adrenocortical Cancer

Active, not recruiting
  • Adrenocortical Carcinoma
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Jan 20, 2023

    Progression-free Survival, Overall Survival, Clinical Benefit Rate Trial in Beijing (Apatinib, SHR-1210)

    Completed
    • Progression-free Survival
    • +3 more
    • Beijing, China
    • +1 more
    May 15, 2020

    Crestal Bone Loss, Survival Rate Trial in Cairo (placement of dental implants)

    Completed
    • Crestal Bone Loss
    • Survival Rate
    • placement of dental implants
    • Cairo, Egypt
      Ain Shams University
    Oct 21, 2023

    Improving Liver Transplant-free Survival in Acute Decompensation

    Not yet recruiting
    • Decompensated Cirrhosis
    • No intervention
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences
    Jul 12, 2023

    Metastatic Cancer Trial in Besançon, Montbéliard (Additional biological samples)

    Recruiting
    • Metastatic Cancer
    • Additional biological samples
    • Besançon, France
    • +1 more
    May 10, 2022

    Severe Toxicity Free Survival Following Childhood Acute

    Recruiting
    • Acute Lymphoblastic Leukemia
      • Copenhagen, Denmark
        Kjeld Schmiegelow
      Dec 9, 2022

      Disease-free Survival of High-risk Head-neck Cutaneous Squamous

      Active, not recruiting
      • Carcinoma, Squamous Cell
      • +5 more
      • Treatment
      • Maastricht, Netherlands
      • +1 more
      Apr 26, 2023

      Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority

      Recruiting
      • Prostate Cancer
      • +2 more
      • Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
      • +7 more
      • Quebec, Canada
        CHUdeQuebec
      Apr 7, 2023

      Disease Free Survival, Overall Survival, Pancreatic Cancer Trial in Milan (use of targeted drugs such as aspirin, B-Blockers,

      Recruiting
      • Disease Free Survival
      • +2 more
      • use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins
      • Milan, Italy
        IRCCS San Raffaele
      Mar 7, 2022

      Textbook Outcome in Colon Carcinoma

      Completed
      • Outcome Assessment
      • Cancer of Colon
      • Colon oncological resection
      • Alicante, Spain
        Hospital General Universitario Dr. Balmis
      Jan 5, 2023

      Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

      Terminated
      Has Results
      • Breast Neoplasms
      • Saint Louis, Missouri
        Washington University School of Medicine
      Oct 31, 2022

      Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

      Recruiting
      • Prostate Cancer
      • +6 more
      • Radiotherapy (SBRT) and/or surgery (metastasectomy)
      • +2 more
      • Leuven, Belgium
        University Hospitals Leuven
      Jun 7, 2022

      to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally

      Recruiting
      • to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
      • Capecitabine 500Mg Oral Tablet
      • Shanghai, China
        Eye & ENT Hospital, Fudan University
      Jul 2, 2023

      Progression-free Survival, Overall Survival, Toxicity Trial in Beijing (pegylated liposomal doxorubicin, pirarubicin)

      Withdrawn
      • Progression-free Survival
      • +2 more
      • Beijing, China
        Peking University People's Hospital
      May 15, 2020

      Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

      Completed
      • Acute Lymphoblastic Leukemia
        • Brno, Czechia
        • +9 more
        Sep 12, 2022

        Metabolic Syndrome, Pregnant Women, Birth Outcomes Trial in Jimma (Exposure, Non exposure)

        Recruiting
        • Metabolic Syndrome
        • +4 more
        • Exposure
        • Non exposure
        • Jimma, Ethiopia
          Jimma University Medical Center
        Jun 28, 2023

        Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)

        Not yet recruiting
        • Prostate Cancer
        • +4 more
        • triptorelin, goserelin, leuprorelin
        • (no location specified)
        Mar 10, 2023

        Non-Squamous NSCLC Trial in Worldwide (Placebo, RG1507, erlotinib [Tarceva])

        Terminated
        Has Results
        • Non-Squamous Non-Small Cell Lung Cancer
        • Placebo
        • +2 more
        • Beverly Hills, California
        • +56 more
        Dec 5, 2020

        Pancreatic Adenocarcinoma Trial in Philadelphia (Niraparib + Nivolumab, Niraparib + Ipilimumab)

        Active, not recruiting
        • Pancreatic Adenocarcinoma
        • Niraparib + Nivolumab
        • Niraparib + Ipilimumab
        • Philadelphia, Pennsylvania
          University of Pennsylvania, Abramson Cancer Center
        Mar 23, 2022

        Contrast-enhanced CT-based Deep Learning Model for Preoperative

        Recruiting
        • Predictive Ability of Contrast-enhanced CT-based Deep Learning Model in Patients With Localised ccRCC
        • +2 more
          • Chongqing, Chongqing, China
            Yingjie Xv
          Oct 12, 2023